See also this year's filing and all EDGAR filings for this company.
PDF Report 0001124105_2023_GYRE_Therapeutics_INC.pdf
Logs
Graph
Absolute values for 0001124105, GYRE Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 28,206,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,000 |
| 3 | remainder_Assets | 234,000 |
| 4 | LiabilitiesCurrent | 16,824,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,104,792 |
| 9 | ResearchAndDevelopmentExpense | 26,017,554 |
| 10 | remainder_Expenses | -20,963,914 |
| 11 | remainder_Revenues | 772,683 |
| 12 | remainder_NetIncome | 496,419 |
| 13 | remainder_ComprehensiveNetIncome | -1,646 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 28,444,000 |
| 1 | Liabilities | 16,824,000 |
| 2 | Expenses | 22,158,432 |
| 3 | Revenues | 772,683 |
| 4 | StockholdersEquity | 11,620,000 |
| 5 | NetIncome | -20,889,330 |
| 6 | ComprehensiveNetIncome | -20,890,153 |
| 7 | BaseVar | 34,348,590 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.196 |
| 9 | EconomicCapitalRatio | 1.60 |
Edgar->Model Mapping
Feature Distribution
Change over Time
